Literature DB >> 22624707

There's a time and a place for MYCN.

Timothy N Phoenix1, Richard J Gilbertson2.   

Abstract

Brain tumors display extensive diversity. In this issue of Cancer Cell, Swartling et al. provide evidence that the temporal and spatial transcriptional programs in neural stem cells underlie a diverse response to the MYCN oncogene, potentially contributing to cancer diversity.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Year:  2012        PMID： 22624707     DOI： 10.1016/j.ccr.2012.05.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  2 in total

1.  Target delivery of MYCN siRNA by folate-nanoliposomes delivery system in a metastatic neuroblastoma model.

Authors:  Qiqi Zhu; Chen Feng; Weiwei Liao; Yan Zhang; Suoqin Tang
Journal:  Cancer Cell Int       Date:  2013-06-27       Impact factor: 5.722

2.  Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN.

Authors:  Lynn Bjerke; Alan Mackay; Meera Nandhabalan; Anna Burford; Alexa Jury; Sergey Popov; Dorine A Bax; Diana Carvalho; Kathryn R Taylor; Maria Vinci; Ilirjana Bajrami; Imelda M McGonnell; Christopher J Lord; Rui M Reis; Darren Hargrave; Alan Ashworth; Paul Workman; Chris Jones
Journal:  Cancer Discov       Date:  2013-05       Impact factor: 39.397
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.